Differences in cortisol levels between preterm and term infants: a systematic review and meta-analysis combined with

Yun Li1,2, Xiaohui Liang2, Limin Cao2

  • 1Department of Neonatal Intensive Care Unit (NICU), Shanxi Children's Hospital(Maternal and Child Health Hospital of Shanxi Province, Maternity Hospital of Shanxi Province), Taiyuan, China.

Insights

Cortisol levels are initially lower in preterm infants compared to term infants, but increase over time. Mendelian randomization suggests a causal link between preterm birth and cortisone, impacting infant health.

Area of Science:

  • Neonatal Physiology
  • Endocrinology
  • Perinatal Medicine

Background:

  • Preterm infants exhibit hypothalamic-pituitary-adrenal (HPA) axis immaturity, but cortisol level differences compared to term infants are unclear.
  • Existing research presents inconsistent findings regarding cortisol levels in preterm versus term infants.

Purpose of the Study:

  • To compare cortisol levels between preterm and term infants using meta-analysis.
  • To investigate the potential causal relationship between preterm birth and cortisone levels via Mendelian randomization.

Main Methods:

  • Systematic literature search across 10 databases up to August 2024.
  • Meta-analysis of 74 studies, including subgroup and meta-regression analyses.
  • Mendelian randomization (MR) analysis with preterm birth as exposure and cortisone as outcome.

Main Results:

  • Preterm infants showed lower cortisol in umbilical cord blood and early peripheral blood, but higher levels after two weeks.
  • Salivary cortisol levels did not significantly differ between groups.
  • MR analysis revealed a negative causal association between preterm birth and cortisone (β = -0.011, P = 0.035).

Conclusions:

  • Cortisol levels in preterm infants follow a dynamic pattern: initially lower, then higher, and eventually comparable to term infants.
  • Mendelian randomization supports a causal relationship between preterm birth and cortisone.
  • Findings may inform clinical management and individualized glucocorticoid strategies for preterm infants.
Abstract